Treatment and Prophylaxis of Gastroenteritis

作者: Michael L. Bennish

DOI: 10.1128/9781555817817.CH11

关键词: Incidence (epidemiology)Plesiomonas shigelloidesPefloxacinQuinoloneImmunologyAntimicrobialDoxycyclineInternal medicineMedicineDiarrheaCystic fibrosis

摘要: This chapter reviews the characteristics of quinolones that make them useful for treatment enteric infections, and role these agents in treating infections. There are a limited number case reports causing arthralgia when used longer periods. The majority have been children with cystic fibrosis, which is known to be associated arthralgia, or prolonged use pefloxacin, most potent initiating arthropathy animals. indications quinolone specific infections clinical conditions. study patients had shortest duration illness, however, was only one did not show reduction diarrhea duration. efficacy antimicrobial prophylaxis traveler's well established by studies conducted starting 1970s doxycycline, then trimethoprim-sulfamethoxazole. at least six fluoroquinolone diarrhea. All showed reducing incidence protection afforded ranged from 76 100%, similar what found using nonquinolone agents. Still, if someone going particularly high-risk area short time, likely markedly diminish risk Plesiomonas shigelloides another putative cause gastroenteritis, strains almost all susceptible quinolones.

参考文章(259)
A. Löffler, H. Grafvon Westphalen, SUCCESSFUL TREATMENT OF CHRONIC SALMONELLA EXCRETOR WITH OFLOXACIN The Lancet. ,vol. 327, pp. 1206- ,(1986) , 10.1016/S0140-6736(86)91179-7
R Bahl, N Bhandari, MK Bhan, M Saxena, A Bagati, Efficacy of antimicrobial treatment in non-dysenteric persistent diarrhoea in a community setting. Acta Paediatrica. ,vol. 85, pp. 1290- 1294 ,(1996) , 10.1111/J.1651-2227.1996.TB13913.X
S.K. Chew, E.H.A. Monteiro, Y.S. Lim, D.M. Allen, A 7-day course of ciprofloxacin for enteric fever. Journal of Infection. ,vol. 25, pp. 267- 271 ,(1992) , 10.1016/0163-4453(92)91519-H
KM Pradhan, NK Arora, A Jena, AK Susheela, MK Bhan, Safety of ciprofloxacin therapy in children: magnetic resonance images, body fluid levels of fluoride and linear growth. Acta Paediatrica. ,vol. 84, pp. 555- 560 ,(1995) , 10.1111/J.1651-2227.1995.TB13694.X
Beatriz Mirelis, Elisenda Miro, Ferran Navarro, Carles A. Ogalla, Joaquin Bonal, Guillermo Prats, Increased resistance to quinolone in Catalonia, Spain. Diagnostic Microbiology and Infectious Disease. ,vol. 16, pp. 137- 139 ,(1993) , 10.1016/0732-8893(93)90009-V
Johan Wiström, Layne O. Gentry, Ann-Chatrin Palmgren, Margaret Price, Carl Erik Nord, Åsa Ljungh, S. Ragnar Norrby, Ecological effects of short-term ciprofloxacin treatment of travellers' diarrhoea Journal of Antimicrobial Chemotherapy. ,vol. 30, pp. 693- 706 ,(1992) , 10.1093/JAC/30.5.693
Jean-Claude Pechère, Quinolones in Intracellular Infections Drugs. ,vol. 45, pp. 29- 36 ,(1993) , 10.2165/00003495-199300453-00007
Wasif Ali Khan, Carlos Seas, Ujjwal Dhar, Mohammed Abdus Salam, Michael L Bennish, Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Annals of Internal Medicine. ,vol. 126, pp. 697- 703 ,(1997) , 10.7326/0003-4819-126-9-199705010-00004
EJ Threlfall, DA Murdoch, NA Banatvala, A Bone, BI Shoismatulloev, LR Ward, Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan The Lancet. ,vol. 351, pp. 339- ,(1998) , 10.1016/S0140-6736(05)78338-0
F Rogerie, D Ott, J Vandepitte, L Verbist, P Lemmens, I Habiyaremye, Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults. Antimicrobial Agents and Chemotherapy. ,vol. 29, pp. 883- 886 ,(1986) , 10.1128/AAC.29.5.883